Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of infection with mycobacterium tuberculosis Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008
Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection Source: Eur Respir J 2013; 41: 644-648 Year: 2013
Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002
Serial interferon-gamma release assay in children with tuberculosis infection Source: Annual Congress 2010 - Tuberculosis in children Year: 2010
Update: T-cell interferon-gamma release assays for the diagnosis of MTB infection Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course Year: 2008
Re-activation of bovine tuberculosis in a patient treated with infliximab Source: Eur Respir J 2008; 32: 229-231 Year: 2008
The role of interferon-gamma release assays for the diagnosis of tuberculosis Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe Year: 2011
Validation of a multiplex assay for measurement of IL-6, IL-8, and TNF-alpha in sputum Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Distinction tuberculosis from Mycobacterium avium complex disease using interferon-gamma release assay Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010
Chemokines in multidrug-resistant tuberculosis: IL-8. IP-10, MCP-1, MIP-1β and RANTES gene expression analysis using real-time PCR Source: Eur Respir J 2004; 24: Suppl. 48, 34s Year: 2004
Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis Source: Eur Respir J 2009; 34: 1118-1126 Year: 2009
The role of IL-12, IL-18, TNF-α, IFN-γ and TGF-β1 in pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy Source: Eur Respir J 2007; 30: 1173-1179 Year: 2007
Characteristics of IL-12p70 and IL-12p40 serum level among active, latent, and contact with tuberculosis patients Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008
Role of interferon-gamma quantification for the diagnosis of pleural tuberculosis: a meta-analysis Source: Eur Respir J 2001; 18: Suppl. 33, 499s Year: 2001
Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006